On April 24th, a team of FDA-supported scientists published a new study in JAMA Pediatrics investigating serious adverse events associated with mRNA vaccines in children.
This comprehensive and well-constructed cohort study focused on post-market surveillance of the COVID vaccines in over 4 million children, confirming the well-documented risk of myocarditis — inflammation of the heart muscle — in adolescents 12-17 who take the mRNA COVID vaccines.
However, the most shocking finding was the discovery of a new safety signal which hadn’t been reported before
